kıbrıs ingiltere londra lefkoşa
DOLAR
7,4034
EURO
9,0055
STERLIN
10,1797
BITCOIN
$32.190
Adana Adıyaman Afyon Ağrı Aksaray Amasya Ankara Antalya Ardahan Artvin Aydın Balıkesir Bartın Batman Bayburt Bilecik Bingöl Bitlis Bolu Burdur Bursa Çanakkale Çankırı Çorum Denizli Diyarbakır Düzce Edirne Elazığ Erzincan Erzurum Eskişehir Gaziantep Giresun Gümüşhane Hakkari Hatay Iğdır Isparta İstanbul İzmir K.Maraş Karabük Karaman Kars Kastamonu Kayseri Kırıkkale Kırklareli Kırşehir Kilis Kocaeli Konya Kütahya Malatya Manisa Mardin Mersin Muğla Muş Nevşehir Niğde Ordu Osmaniye Rize Sakarya Samsun Siirt Sinop Sivas Şanlıurfa Şırnak Tekirdağ Tokat Trabzon Tunceli Uşak Van Yalova Yozgat Zonguldak
LONDRA
Yağmurlu
9°C
LONDRA
9°C
Yağmurlu
22 Oca, Cum Çoğunlukla Bulutlu
10°C
23 Oca, Cmt Parçalı Güneşli Sağanak Yağışlı
5°C
24 Oca, Paz Bulutlu
4°C
25 Oca, Pzt Çoğunlukla Bulutlu
5°C

No 10: UK to get “first access” to Oxford’s Covid-19 vaccine

No 10: UK to get “first access” to Oxford’s Covid-19 vaccine
24.08.2020
0
A+
A-

Downing Street has insisted the UK will get “first access” to a coronavirus vaccine developed by Oxford University amid reports that Donald Trump is considering fast-tracking its approval.

Oxford University’s vaccine, currently being developed with pharmaceutical company AstraZeneca, is considered one of the leading candidates among more than 100 teams vying to produce one.

The White House is considering granting emergency authorisation for the vaccine in October, the Financial Times reported, citing sources familiar with the plan.

A Number 10 spokesman said the UK Government has struck a deal with AstraZeneca to get “first access” to it once approved.

We have been clear that we will only roll out a vaccine once it is deemed safe and effective by our regulators,” said the Downing Street spokesman.

“AstraZeneca have entered into a number of agreements with other countries, they have the global licensing agreement with Oxford, but we have been clear: once it has been found to be effective, we have signed a deal for 100 million doses which means that once it is effective, the UK will get first access.”

The US has the highest number of deaths related to coronavirus as well as most cases of any country, according to Johns Hopkins University.

Almost 177,000 people are confirmed to have died with the virus, while more than 5.7 million have been infected.

The White House declined to comment on the claims. AstraZeneca said that it had not discussed the possibility of fast-tracking approval with the US authorities, adding: “It would be premature to speculate on that possibility.”

Yorumlar

Henüz yorum yapılmamış. İlk yorumu yukarıdaki form aracılığıyla siz yapabilirsiniz.